Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-06-08

FDA Approved: ALLEGRA-D ALLERGY AND CONGESTION — Supplemental Application (Chattem, Inc.)

View source ↗

Summary

The FDA approved a supplemental NDA for Allegra-D Allergy and Congestion (fexofenadine HCl and pseudoephedrine HCl) submitted by Chattem, Inc., per the accompan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALLEGRA-D ALLERGY AND CONGESTION (Fexofenadine hydrochloride and pseudoephedrine hydrochloride)

Snippet

SUPPL AP for ALLEGRA-D ALLERGY AND CONGESTION (FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE)